CLPTNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
ClearPoint Neuro, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 3, 2026
$9.17+0.10 (+1.10%)
Close on Oct 19, 2026
- Market cap
- $276.63M
- P/E (TTM)
- –
- Dividend yield
- –
ClearPoint Neuro, Inc. revenue by segment
By business segment
By product or service
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Product revenue | $23.86M | $18.63M | $10.60M | $12.79M | $11.91M | $8.83M | $9.80M | $6.69M | $7.02M | 64.5% | +28.1% |
| Biologics and drug delivery | $19.04M | $17.31M | $13.60M | $9.12M | $6.80M | $5.20M | $2.41M | $951.94K | $675.81K | 51.5% | +10.0% |
| Neurosurgery navigation and therapy | $14.83M | $10.29M | $8.52M | – | – | – | – | – | – | 40.1% | +44.2% |
| Neurosurgery Navigation and Therapy - Disposable Products | $14.83M | $10.29M | – | – | – | – | – | – | – | 40.1% | +44.2% |
| Service and other revenue | $13.11M | $12.76M | $13.35M | $7.76M | $4.39M | $4.00M | $1.42M | $668.25K | $355.52K | 35.5% | +2.7% |
| Biologics and Drug Delivery - Services and License Fees | $11.70M | $11.70M | $11.45M | $5.43M | $3.44M | – | – | – | – | 31.7% | -0.0% |
| Biologics and Drug Delivery - Disposable Products | $7.34M | $5.61M | $2.15M | $3.69M | $3.35M | $1.53M | $1.52M | – | – | 19.8% | +30.9% |
| Capital equipment and software | $3.10M | $3.80M | $1.83M | $2.31M | $1.43M | $1.42M | $1.66M | – | – | 8.4% | -18.3% |
| Capital Equipment and Software-Related Service | $2.10M | $2.30M | – | – | – | – | – | – | – | 5.7% | -8.7% |
| Capital Equipment and Software - Systems and Software Products | $1.69M | $2.74M | $860.00K | $1.51M | $864.00K | $1.09M | $1.36M | – | – | 4.6% | -38.2% |
| Capital Equipment and Software - Services | $1.41M | $1.06M | $973.00K | $795.00K | $569.00K | $325.00K | $306.00K | – | – | 3.8% | +33.0% |
| Functional Neurology [Member] | – | – | – | – | – | – | – | $5.31M | $5.23M | – | – |
| Capital Equipment | – | – | – | – | – | – | – | $420.04K | $1.12M | – | – |
| Capital Equipment and Other [Member] | – | – | – | – | – | – | – | $393.02K | $355.52K | – | – |
| Capital Equipment and Other [Member] | – | – | – | – | – | – | – | $393.02K | $355.52K | – | – |
| Biologics And Drug Delivery [Member] | – | – | – | – | – | – | – | $175.22K | – | – | – |
| Capital Equipment Related Service Revenue | – | $2.30M | $1.10M | – | – | $500.00K | $228.00K | $142.61K | – | – | – |
| Remaining Performance Obligations Capital Equipment-Related Service Revenue | – | – | – | – | – | $500.00K | $1.10M | $303.91K | – | – | – |
| Functional Neurology [Member] | – | – | – | – | – | – | – | $100.00K | – | – | – |
| Therapy - Services | – | – | – | – | – | – | $225.00K | $100.00K | – | – | – |
| Functional Neurosurgery Navigation - Disposable Products | – | – | – | – | – | – | $6.88M | $5.31M | – | – | – |
| Biologics and Drug Delivery - Disposable Products | – | – | – | – | – | – | $1.46M | $913.42K | – | – | – |
| Capital Equipment and Software - Systems and Software Products | – | – | – | – | – | – | $1.04M | $420.04K | – | – | – |
| Product - Product Revenue | – | – | – | – | – | – | $9.48M | $6.69M | – | – | – |
| Biologics and Drug Delivery - Services | – | – | – | – | – | – | $889.70K | $175.22K | – | – | – |
| Capital Equipment and Software - Services | – | – | – | – | – | – | $625.87K | $393.02K | – | – | – |
| Services - Service Revenue | – | – | – | – | – | – | $1.74M | $668.25K | – | – | – |
| Therapy - Disposable Products | – | – | – | – | – | – | $96.93K | – | – | – | – |
| Biologics and Drug Delivery - Services | – | – | – | – | $3.44M | $3.67M | $890.00K | – | – | – | – |
| Functional neurosurgery navigation and therapy | – | – | $8.52M | $9.12M | $8.07M | $6.21M | $7.14M | – | – | – | – |
| Functional Neurosurgery Navigation and Therapy - Services | – | – | – | $1.54M | $375.00K | $0 | $225.00K | – | – | – | – |
| Functional Neurosurgery Navigation and Therapy - Disposable Products | – | – | – | $7.59M | $7.70M | $6.21M | $6.92M | – | – | – | – |
| Functional Neurosurgery Navigation and Therapy - Services | – | – | $931.00K | $1.54M | – | – | – | – | – | – | – |
| Functional Neurosurgery Navigation and Therapy - Disposable Products | – | – | $7.59M | $7.59M | – | – | – | – | – | – | – |
| Neurosurgery Navigation and Therapy - Disposable Products | – | $10.29M | $7.59M | – | – | – | – | – | – | – | – |
| Neurosurgery Navigation and Therapy - Services | – | $0 | $931.00K | – | – | – | – | – | – | – | – |
By region
From the segment and revenue-disaggregation notes of ClearPoint Neuro's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.